Literature DB >> 27697089

Human cysticercosis in Portugal: long gone or still contemporary?

M Vilhena1,2, A G Fonseca2,3, S Dias3, J Marques DA Silva1, J Torgal2,3.   

Abstract

Cysticercosis, a leading cause of acquired epilepsy in developing countries, has been controlled or eradicated in industrialized countries. This paradigm has recently been challenged, with human neurocysticercosis (NCC) being increasingly diagnosed in these countries. In order to assess the NCC burden in Portugal, a retrospective study on NCC hospitalizations (2006-2013) was conducted based on the national database on hospital morbidity: 357 hospitalized cases were detected. NCC was most frequent in the following age groups: 20-64 years (n = 197, 55·2%) >64 years (n = 111, 31·1%), and <20 years (n = 49, 13·7%). In the Norte and Centro regions cases tended to be older than in the Lisboa and Vale do Tejo Region. The results raise concerns for imported and autochthonous disease, suggesting the Lisboa and Vale do Tejo Region, due to its higher frequency of cases at younger ages, as a priority for research and intervention, and further suggest that NCC should be under surveillance (notifiable). The National Observatory of Cysticercosis and Taeniasis has been established and will define NCC cases as well as monitoring and surveillance.

Entities:  

Keywords:  Neurocysticercosis; Portugal; surveillance

Mesh:

Year:  2016        PMID: 27697089      PMCID: PMC9507589          DOI: 10.1017/S0950268816002284

Source DB:  PubMed          Journal:  Epidemiol Infect        ISSN: 0950-2688            Impact factor:   4.434


  8 in total

1.  Growing frequency of neurocysticercosis in Madrid (Spain).

Authors:  A Esquivel; F Diaz-Otero; S Gimenez-Roldan
Journal:  Neurologia       Date:  2005-04       Impact factor: 3.109

Review 2.  Control of the taeniosis/cysticercosis complex: future developments.

Authors:  Ana Flisser; Rossanna Rodríguez-Canul; Arve Lee Willingham
Journal:  Vet Parasitol       Date:  2006-05-24       Impact factor: 2.738

Review 3.  Neurocysticercosis in Western Europe: a re-emerging disease?

Authors:  Oscar H Del Brutto
Journal:  Acta Neurol Belg       Date:  2012-04-18       Impact factor: 2.396

Review 4.  Taenia solium cysticercosis.

Authors:  Héctor H García; Armando E Gonzalez; Carlton A W Evans; Robert H Gilman
Journal:  Lancet       Date:  2003-08-16       Impact factor: 79.321

Review 5.  Neurocysticercosis in Europe: Still a public health concern not only for imported cases.

Authors:  S Fabiani; F Bruschi
Journal:  Acta Trop       Date:  2013-07-17       Impact factor: 3.112

Review 6.  Epidemiology and management of cysticercosis and Taenia solium taeniasis in Europe, systematic review 1990-2011.

Authors:  Lorenzo Zammarchi; Marianne Strohmeyer; Filippo Bartalesi; Elisa Bruno; José Muñoz; Dora Buonfrate; Alessandra Nicoletti; Héctor Hugo García; Edoardo Pozio; Alessandro Bartoloni
Journal:  PLoS One       Date:  2013-07-29       Impact factor: 3.240

7.  [Neurocysticercosis. An imaging analysis of 35 cases].

Authors:  C Morgado; L B Gomes; J G de Campos
Journal:  Acta Med Port       Date:  1994-05

8.  Taenia solium in Europe: Still endemic?

Authors:  Brecht Devleesschauwer; Alberto Allepuz; Veronique Dermauw; Maria V Johansen; Minerva Laranjo-González; G Suzanne A Smit; Smaragda Sotiraki; Chiara Trevisan; Nicola A Wardrop; Pierre Dorny; Sarah Gabriël
Journal:  Acta Trop       Date:  2015-08-12       Impact factor: 3.112

  8 in total
  1 in total

Review 1.  One Health-ness Evaluation of Cysticercosis Surveillance Design in Portugal.

Authors:  Ana Gloria Fonseca; Jorge Torgal; Daniele de Meneghi; Sarah Gabriël; Ana Cláudia Coelho; Manuela Vilhena
Journal:  Front Public Health       Date:  2018-03-13
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.